Results 31 to 40 of about 675 (151)

Die Kaltplasma‐Technologie in der Behandlung von Menschen mit chronischen Wunden [PDF]

open access: yesJ Dtsch Dermatol Ges
Zusammenfassung Chronische Wunden stellen eine erhebliche Belastung sowohl für Patienten als auch für Gesundheitssysteme dar. Die Kaltplasma‐Technologie hat sich bei der Behandlung von Menschen mit chronischen Wunden in den letzten Jahren zunehmend etabliert. Mittlerweile sind verschiedene Kaltplasma‐Geräte verfügbar.
Bekeschus S   +3 more
europepmc   +2 more sources

Medical Gas Plasma—A Potent ROS-Generating Technology for Managing Intraoperative Bleeding Complications

open access: yesApplied Sciences, 2022
Cold medical gas plasmas are under pre-clinical investigation concerning their hemostatic activity and could be applied for intra-operative bleeding control in the future.
Lea Miebach   +3 more
doaj   +1 more source

Combined In Vitro Toxicity and Immunogenicity of Cold Plasma and Pulsed Electric Fields

open access: yesBiomedicines, 2022
In modern oncology, therapies are based on combining monotherapies to overcome treatment resistance and increase therapy precision. The application of microsecond-pulsed electric fields (PEF) is approved to enhance local chemotherapeutic drug uptake ...
Christina M. Wolff   +2 more
doaj   +1 more source

Conductive Gas Plasma Treatment Augments Tumor Toxicity of Ringer’s Lactate Solutions in a Model of Peritoneal Carcinomatosis

open access: yesAntioxidants, 2022
Reactive species generated by medical gas plasma technology can be enriched in liquids for use in oncology targeting disseminated malignancies, such as metastatic colorectal cancer.
Lea Miebach   +3 more
doaj   +1 more source

Evaluation of the effectiveness of kINPen Med plasma jet and bioactive agent therapy in a rat model of wound healing [PDF]

open access: yesBiointerphases, 2018
Chronic nonhealing wounds, particularly those complicated by multidrug resistant infections, represent a major health and economic challenge. Plasma treatment promotes wound repair due to its antimicrobial, angiogenic, and cell modulating properties.
Rory, Breathnach   +4 more
openaire   +2 more sources

Gas Plasma Protein Oxidation Increases Immunogenicity and Human Antigen-Presenting Cell Maturation and Activation

open access: yesVaccines, 2022
Protein vaccines rely on eliciting immune responses. Inflammation is a prerequisite for immune responses to control infection and cancer but is also associated with disease onset.
Ramona Clemen   +3 more
doaj   +1 more source

Reactive species driven oxidative modifications of peptides—Tracing physical plasma liquid chemistry [PDF]

open access: yes, 2021
The effluence of physical plasma consists of a significant share of reactive species, which may interact with biomolecules and yield chemical modifications comparable to those of physiological processes, e.g., post-translational protein modifications ...
Larissa Milena Busch   +11 more
core   +1 more source

The Anticancer Efficacy of Plasma-Oxidized Saline (POS) in the Ehrlich Ascites Carcinoma Model In Vitro and In Vivo

open access: yesBiomedicines, 2021
Cold physical plasma, a partially ionized gas rich in reactive oxygen species (ROS), is receiving increasing interest as a novel anticancer agent via two modes.
Walison Augusto Silva Brito   +9 more
doaj   +1 more source

Elevated H2AX Phosphorylation Observed with kINPen Plasma Treatment Is Not Caused by ROS-Mediated DNA Damage but Is the Consequence of Apoptosis [PDF]

open access: yesOxidative Medicine and Cellular Longevity, 2019
Phosphorylated histone 2AX (γH2AX) is a long-standing marker for DNA double-strand breaks (DSBs) from ionizing radiation in the field of radiobiology. This led to the perception ofγH2AX being a general marker of direct DNA damage with the treatment of other agents such as low-dose exogenous ROS that unlikely act on cellular DNA directly.
Sander Bekeschus   +8 more
openaire   +2 more sources

Gas Plasma-Treated Prostate Cancer Cells Augment Myeloid Cell Activity and Cytotoxicity

open access: yesAntioxidants, 2020
Despite recent improvements in cancer treatment, with many of them being related to foster antitumor immunity, tumor-related deaths continue to be high. Novel avenues are needed to complement existing therapeutic strategies in oncology.
Sander Bekeschus   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy